Form 4: Nutex Health Executive Pamela Montgomery Settles Restricted Stock Units
SEC Form 4 Filing
Pamela Montgomery, Chief Legal Officer of Nutex Health, Inc., settled restricted stock units (RSUs) for common stock on March 12, 2024.
Summary
- On March 12, 2024, Pamela Montgomery, Chief Legal Officer of Nutex Health, Inc., settled 16,502 restricted stock units (RSUs).
- This settlement resulted in the acquisition of 16,502 shares of common stock and the disposal of 45,004 shares.
- Following the transaction, Ms. Montgomery directly owns 16,501 derivative securities.
- The RSUs vested according to the Restricted Stock Unit Agreement dated April 1, 2023, with installments vesting on April 1, 2023, March 1, 2024, and a future vesting date of March 1, 2025.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to executive compensation. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about stock transactions.
Positives
- The vesting of RSUs indicates a continued commitment by the executive to the company's long-term success.
Future Outlook
The remaining RSUs will vest on March 1, 2025, as per the agreement.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into insider transactions, which are closely monitored by investors.
Stakeholder Impact
- Shareholders can monitor insider transactions through this filing, providing insights into management's perspective on the company's value.
Key Dates
| Date | Description |
|---|---|
| April 1, 2023 | Date of the Restricted Stock Unit Agreement between Nutex Health and Pamela Montgomery; initial 1/3 of RSUs vested. |
| March 1, 2024 | Second vesting date for 1/3 of the RSUs. |
| March 12, 2024 | Date of the transaction reported in the Form 4, settlement of RSUs for common stock. |
| March 1, 2025 | Final vesting date for 1/3 of the RSUs. |
| March 14, 2024 | Date of signature on the Form 4. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.